Your selections:
An in vivo tumor model exploiting metabolic response as a biomarker for targeted drug development
- Cullinane, Carleen, Dorow, Donna S., Kansara, Maya, Conus, Nelly, Binns, David, Hicks, Rodney J., Ashman, Leonie Kay, McArthur, Grant A., Thomas, David M.
Immunomodulatory activities of pixatimod: Emerging nonclinical and clinical data, and its potential utility in combination with PD-1 inhibitors
- Hammond, Edward, Haynes, Nicole M., Cullinane, Carleen, Brennan, Todd V., Bampton, Darryn, Handley, Paul, Karoli, Tomislav, Lanksheer, Fleur, Lin, Liwen, Yang, Yiping, Dredge, Keith
- Liu, Zheng, Martin, Jennifer H., Hatzimihalis, Athena, Campbell, Ian, Crowley, Simone, Beale, Phillip J., Karapetis, Christos S., Price, Timothy, Burge, Mathew E., Michael, Michael, Liauw, Winston, Mclachlan, Sue-Anne, Link, Emma, Matera, Anetta, Thompson, Michael, Jefford, Michael, Hicks, Rod J., Cullinane, Carleen
Are you sure you would like to clear your session, including search history and login status?